Prostate News and Research

RSS

New method targeting hypermethylation detects ovarian cancer in the blood

Fox Chase Cancer Center researchers have found a new way to detect ovarian cancer in the blood. Reported in the Sept. 15, 2004, issue of Cancer Research, the new method targets hypermethylation--one mechanism used by cancer cells to turn off genes that protect against tumor development.

16 Sep 2004

Drug combo may have a greater impact on cancer development

Cancer researchers have long suggested that new targeted drugs may work best when paired with other therapies. In a new study published today in Cancer Research, scientists have taken some of the first steps to demonstrate this synergy in mouse and cell line models.

16 Sep 2004

Newly completed Chromosome 5 sequence will be a powerful tool for scientists trying to understand human disease

Four years after publicly revealing the official draft human genetic sequence, researchers have reached the halfway point in dotting the i's and crossing the t's of the genetic sentences describing how to build a human.

16 Sep 2004

Cryoablation preferred option for treatment of breast fibroadenoma

Sanarus Inc., a developer of minimally invasive diagnostic and treatment tools for breast disease, announced today that twelve-month follow-up data from a peer-reviewed, prospective multicenter study demonstrates that cryoablation is a preferred first-line treatment for breast fibroadenoma for women who do not want to undergo open surgery.

14 Sep 2004

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

If future studies show their test -- measuring the level of activity of a signaling pathway called Hedgehog -- can predict which prostate cancers will spread, the results could revolutionize decision making processes for prostate cancer patients, the researchers say.

13 Sep 2004

PSA test is now all but useless for predicting prostate cancer risk

The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.

10 Sep 2004

Smallest patient to receive surgery to correct an abdominal disorder using an advanced surgical robotic system

After spending more than seven months in the hospital following his premature birth, the parents of Dakota Templeton were hopeful that his worst medical challenges were behind him. Unfortunately, those hopes were not realized.

10 Sep 2004

Studies of human genetic variation have found strong evidence for the action of natural selection

One of the most comprehensive studies of the forces that have shaped patterns of human genetic variation has found strong evidence for the action of natural selection, which may help explain why certain people are at risk for a variety of conditions and others are not.

8 Sep 2004

Cancers, including colon, prostate, and leukemia, continue to grow unchecked

Many cancers, including colon, prostate, and leukemia, continue to grow unchecked because they do not respond to a signal to die and stop proliferating from Transforming Growth Factor-beta (TGF-b).

8 Sep 2004

Men's magazines don’t inform men about prostate and colon cancer screening

Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men’s magazines.

8 Sep 2004

Study reveals what may be the earliest step in the development of prostate cancer

The finding could open the door to new tests that predict whether the cancer will become aggressive and the development of treatments to prevent the condition from progressing.

2 Sep 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Scientists have uncovered a key driver behind the progression of prostate cancer

Scientists at Fred Hutchinson Cancer Research Center have uncovered a key driver behind the progression of prostate cancer, a discovery that the researchers believe could spawn new treatments to prevent the cancer's spread and extend survival.

23 Aug 2004

New database about a group of genes associated with multidrug resistance in cancerous tumors

Scientists at the National Cancer Institute, have created a database of information about a group of genes associated with multidrug resistance in cancerous tumors.

23 Aug 2004

Dual-action compound shows promise in killing prostate cancer cells

Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

22 Aug 2004

Test for identifying which cases of prostate cancer will become life threatening

Karin Drotschmann, Ph.D., a researcher at Wake Forest University Baptist Medical Center, has won the “New Investigator Award” from the Department of Defense, Prostate Cancer Research Program, for her work to develop a test for identifying which cases of prostate cancer will become life threatening.

20 Aug 2004

Study to compare prostate surgery and drugs

The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.

20 Aug 2004

Combination therapies improve prostate cancer survival rates

The addition of six months of androgen suppression therapy (AST) to radiation therapy improves survival of patients with clinically localized prostate cancer, according to a study in the current issue of the Journal of the American Medical Association.

18 Aug 2004

New blood test to detect ovarian cancer

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

16 Aug 2004

Blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

15 Aug 2004

Prostate News and Research

New method targeting hypermethylation detects ovarian cancer in the blood

Drug combo may have a greater impact on cancer development

Newly completed Chromosome 5 sequence will be a powerful tool for scientists trying to understand human disease

Cryoablation preferred option for treatment of breast fibroadenoma

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

PSA test is now all but useless for predicting prostate cancer risk

Smallest patient to receive surgery to correct an abdominal disorder using an advanced surgical robotic system

Studies of human genetic variation have found strong evidence for the action of natural selection

Cancers, including colon, prostate, and leukemia, continue to grow unchecked

Men's magazines don’t inform men about prostate and colon cancer screening

Study reveals what may be the earliest step in the development of prostate cancer

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Scientists have uncovered a key driver behind the progression of prostate cancer

New database about a group of genes associated with multidrug resistance in cancerous tumors

Dual-action compound shows promise in killing prostate cancer cells

Test for identifying which cases of prostate cancer will become life threatening

Study to compare prostate surgery and drugs

Combination therapies improve prostate cancer survival rates

New blood test to detect ovarian cancer

Blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News